HOME >> BIOLOGY >> NEWS
Weizmann Institute scientists develop a general 'control switch' for protein activity

Our bodies could not maintain their existence without thousands of proteins performing myriad vital tasks within cells. Since malfunctioning proteins can cause disease, the study of protein structure and function can lead to the development of drugs and treatments for numerous disorders. For example, the discovery of insulins role in diabetes paved the way for the development of a treatment based on insulin injections. Yet, despite enormous research efforts led by scientists worldwide, the cellular function of numerous proteins is still unknown. To reveal this function, scientists perform various genetic manipulations to increase or, conversely, decrease the production of a certain protein, but existing manipulations of this sort are complicated and do not fully meet the researchers needs.

Prof. Mordechai Moti Liscovitch and graduate student Oran Erster of the Weizmann Institutes Biological Regulation Department, together with Dr. Miri Eisenstein of Chemical Research Support, have recently developed a unique switch that can control the activity of any protein, raising it several-fold or stopping it almost completely. The method provides researchers with a simple and effective tool for exploring the function of unknown proteins, and in the future the new technique may find many additional uses.

The switch has a genetic component and a chemical component: Using genetic engineering, the scientists insert a short segment of amino acids into the amino acid sequence making up the protein. This segment is capable of binding strongly and selectively to a particular chemical drug, which affects the activity level of the engineered protein by increasing or reducing it. When the drug is no longer applied, or when it is removed from the system, the protein returns to its natural activity level.

As reported recently in the journal Nature Methods, the first stage of the method consists of preparing a set of genetically engineered proteins (called
'"/>

Contact: Jennifer Manning
jennifer@acwis.org
212-895-7952
American Committee for the Weizmann Institute of Science
19-Jun-2007


Page: 1 2 3

Related biology news :

1. Weizmann Institute scientists discover a control mechanism for metastasis
2. Weizmann scientists discover a new line of communication between nervous system cells
3. Weizmann Institute scientists discover a key player in embryonic muscle development
4. Weizmann Institute scientists discover genes that can slow cell division and may fight cancer
5. Weizmann Women & Science Award presented to Dr. Mary-Claire King
6. Mary-Claire King to receive the 2006 Weizmann Women & Science Award
7. Weizmann Institute scientists discover a molecular security mechanism for keeping mutations in check
8. Weizmann Institute suggests that immune cells help to maintain cognition and brain cell renewal
9. Weizmann Institute scientists discover how substitutions are made for injured genes
10. Weizmann Insitute scientists show how proteins beat the evolutionary stakes
11. Technology award presented to Weizmann Institute scientist

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/5/2019)... ... 05, 2019 , ... Catalent, the leading global provider of ... consumer health products, today announced it will present at the upcoming World Orphan ... – 14, 2019. , On Wednesday, Nov. 13 at 3:20 p.m., Philip Wills, ...
(Date:11/2/2019)... ... November 01, 2019 , ... Stay on top of current hot ... industries. Access to all webinars is free, so be sure to register today to ... Visit http://www.xtalks.com to see our upcoming webinars: , CLINICAL OPERATIONS , November ...
(Date:10/30/2019)... ... October 30, 2019 , ... PathSensors, Inc. will ... TN from Tuesday, November 5, 2019, to Thursday, November 7, 2019. This convergence ... nuclear) and IED (explosive) threats. Delegates and experts from over 30 countries will ...
Breaking Biology News(10 mins):
(Date:11/12/2019)... ... 12, 2019 , ... REPROCELL Inc. a stem cell and ... Pharma to provided preclinical screening and drug sensitivity for its portfolio of oncology ... of unique and genetically edited cell lines from various tumors. The data generated ...
(Date:11/12/2019)... ... November 12, 2019 , ... Bode Technology (Bode) , ... Genealogy, Melinde Lutz Byrne, to the organization. Byrne’s team will strengthen efforts in ... to law enforcement through proven genealogy and DNA analysis methods. , Byrne’s hiring ...
(Date:11/6/2019)... ... November 06, 2019 , ... Diversified Technologies, Inc. has introduced a ... per hour to improve processing. , The DTI Industrial PEF Unit can pre-treat whole ... increase juice yields by up to 50% and achieve up to an 80% reduction ...
(Date:11/5/2019)... ... November 05, 2019 , ... Focal Healthcare ... Mark for its Fusion Bx 2.0 prostate fusion biopsy solution. By combining information ... Bx 2.0 will give urologists across Europe the ability to perform targeted transrectal ...
Breaking Biology Technology:
Cached News: